thalidomide has been researched along with Benign Cerebellar Neoplasms in 5 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Excerpt | Relevance | Reference |
---|---|---|
"After the second recurrence of spinal seeding in hemangioblastoma not associated to von-Hippel-Lindau disease, we treated an adult female patient with thalidomide 200 mg orally/day at night for longer than 1 year." | 7.72 | Stabilization of a progressive hemangioblastoma under treatment with thalidomide. ( Birner, P; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Hainfellner, JA; Marosi, C; Piribauer, M; Prayer, D; Weinländer, G, 2004) |
"Neutropenia was the main side effect of the metronomic therapy." | 5.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
"After the second recurrence of spinal seeding in hemangioblastoma not associated to von-Hippel-Lindau disease, we treated an adult female patient with thalidomide 200 mg orally/day at night for longer than 1 year." | 3.72 | Stabilization of a progressive hemangioblastoma under treatment with thalidomide. ( Birner, P; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Hainfellner, JA; Marosi, C; Piribauer, M; Prayer, D; Weinländer, G, 2004) |
"Neutropenia was the main side effect of the metronomic therapy." | 1.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hauser, P | 1 |
Vancsó, I | 1 |
Pócza, T | 1 |
Schuler, D | 1 |
Garami, M | 1 |
Fernández Salazar, LI | 1 |
Velayos Jiménez, B | 1 |
Fernández Galante, I | 1 |
Aller de la Fuente, R | 1 |
González Hernández, JM | 1 |
Nygaard, R | 1 |
Kivivuori, SM | 1 |
Rigual, D | 1 |
Qiu, J | 1 |
Fenstermaker, RA | 1 |
Fabiano, AJ | 1 |
Piribauer, M | 1 |
Czech, T | 1 |
Dieckmann, K | 1 |
Birner, P | 1 |
Hainfellner, JA | 1 |
Prayer, D | 1 |
Fazeny-Dörner, B | 1 |
Weinländer, G | 1 |
Marosi, C | 1 |
5 other studies available for thalidomide and Benign Cerebellar Neoplasms
Article | Year |
---|---|
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemothera | 2013 |
[Efficacy of thalidomide in digestive bleeding caused by angiodysplasias].
Topics: Aged; Angiodysplasia; Angiogenesis Inhibitors; Cardiovascular Diseases; Cerebellar Neoplasms; Cerebe | 2009 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap | 2012 |
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplas | 2013 |
Stabilization of a progressive hemangioblastoma under treatment with thalidomide.
Topics: Angiogenesis Inhibitors; Cerebellar Neoplasms; Disease Progression; Female; Hemangioblastoma; Humans | 2004 |